Preoperative considerations for patients who are chronic cannabis users are critical due to the potential impact on respiratory health and the implications for anesthesia. Chronic cannabis smoking is linked to symptoms similar to those found in chronic tobacco users, including chronic bronchitis characterized by increased sputum production, coughing, wheezing, and dyspnea. These symptoms are supported by bronchoscopic and histologic findings showing bronchial inflammation and alterations in lung tissue, indicating that cannabis smoke can significantly compromise the respiratory system.
During the preoperative evaluation, patients should be thoroughly questioned about their cannabis use, including duration, frequency, route of use, and timing of the last intake. This information is vital for guiding safe perioperative care and for assessing the risk of acute intoxication, which has distinct anesthetic implications. Symptoms of acute cannabis intoxication, such as escalating anxiety, paranoia, or psychosis, can make recovery from anesthesia especially difficult and may be confused with other serious conditions like malignant hyperthermia, serotonin syndrome, neuroleptic malignant syndrome, overdose of 3,4-methylenedioxymethamphetamine (MDMA), or thyrotoxicosis. A delay of anesthetic induction may also be appropriate until resolution of tachycardia and/or postural hypotension in acutely intoxicated patients.
Additionally, the potential for cannabis withdrawal symptoms should be considered, emphasizing the importance of a detailed patient history over relying solely on toxicology screens, which may not accurately reflect the timing or degree of cannabis use. For patients with a history of angina or other cardiovascular issues, anesthesiologists should assess changes in functional capacity related to cannabis use and may need to delay elective surgery or anesthetic induction to mitigate increased risks of myocardial infarction or cardiovascular instability.
The risk of airway hyperreactivity in cannabis smokers also necessitates a careful preoperative respiratory evaluation. Obtaining informed consent from patients who are acutely intoxicated presents ethical concerns due to impaired memory and perception, suggesting that similar care and considerations should be applied as with any intoxicated patient.
In conclusion, the preoperative evaluation of cannabis users should extend beyond standard practices to include a comprehensive assessment of cannabis use patterns and its potential effects on respiratory, cardiovascular, and psychological health. This approach aims to ensure the safety and effectiveness of anesthesia and perioperative care, with a focus on individualized patient assessment and management strategies.In summary, anesthesiologists should assess patients for indications of acute cannabis intoxication, while also investigating their usage habits. Additional examinations should concentrate on the cardiovascular, respiratory, and psychological systems to reduce the likelihood of adverse perioperative results. Routine baseline laboratory tests are not suggested for individuals in this group. Drug screening can offer qualitative insights into cannabis consumption over the last 30 days. Any further testing should be guided by clinical discretion and adhere to established guidelines and protocols.
